Get started
Author

Majbritt Jeppesen

Observed names: Jeppesen, Majbritt, M. Jeppesen
ORCID: 0000-0003-2453-216X
Observed ORCID: 0000-0003-2453-216X
OpenAlex ID: A5017155333
Serum C‐peptide levels and breast cancer risk: Results from the European prospective investigation into cancer and nutrition (EPIC)
2006 · Martijn Verheus, Petra H.M. Peeters, et al. · International Journal of Cancer · 102
PDF
Impaired Renal HCO3 - Excretion in Cystic Fibrosis
2020 · Peder Berg, Samuel L. Svendsen, et al. · Journal of the American Society of Nephrology · 54
Cystic fibrosis in the kidney: new lessons from impaired renal HCO3− excretion
2021 · Peder Berg, Majbritt Jeppesen, et al. · Current Opinion in Nephrology & Hypertension · 26
Challenged Urine Bicarbonate Excretion as a Measure of Cystic Fibrosis Transmembrane Conductance Regulator Function in Cystic Fibrosis
2022 · Peder Berg, Mads V. Sorensen, et al. · Annals of Internal Medicine · 20
Management of Cystic Fibrosis during COVID-19: Patient Reported Outcomes based remote follow-up among CF patients in Denmark – A feasibility study
2021 · Lotte Rodkjær, Majbritt Jeppesen, et al. · Journal of Cystic Fibrosis · 13
PDF
Close monitoring and early intervention: management principles for cystic fibrosis in Denmark
2024 · Tavs Qvist, Bibi Uhre Nielsen, et al. · Apmis · 12
PDF
Change in pulmonary pathogens 3 years after elexacaftor/tezacaftor/ivacaftor: an observational study in the Danish cystic fibrosis cohort
2025 · Maria Pals Bendixen, Majbritt Jeppesen, et al. · Clinical Microbiology and Infection · 10
Real‐world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis
2024 · Thomas Bryrup, Daniel Faurholt‐Jepsen, et al. · Apmis · 10
Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation
2022 · Matilde B. Ørum, Frederikke F. Rönsholt, et al. · Pediatric Pulmonology · 10
Lung function improvement on triple modulators: high-resolution, nationwide data from the Danish Cystic Fibrosis Cohort
2024 · Christian Leo-Hansen, Daniel Faurholt-Jepsen, et al. · ERJ Open Research · 8
The challenged urine bicarbonate excretion test in cystic fibrosis: A comprehensive analysis of urine acid/base parameters
2024 · Amalie Q. Rousing, Majbritt Jeppesen, et al. · Acta Physiologica · 7
PDF
Severe hepatotoxicity is uncommon following the introduction of Elexacaftor/Tezacaftor/Ivacaftor: A real-world two-years follow-up study of the Danish cystic fibrosis cohort
2025 · Christine Højte, Mette Frahm Olsen, et al. · Journal of Cystic Fibrosis · 6
PDF
Elexacaftor/tezacaftor/ivacaftor corrects salt-wasting in cystic fibrosis
2025 · Peder Berg, Amalie Quist Rousing, et al. · Journal of Cystic Fibrosis · 5
Pregnancy and infection
2024 · Ellen Moseholm, Lene Ryom, et al. · Ugeskrift for Læger · 4
Treatment outcomes of nontuberculous mycobacterial infection in the Danish Cystic Fibrosis Cohort 2012-23
2025 · Christian Leo-Hansen, Bibi U Nielsen, et al. · Journal of Cystic Fibrosis · 1
PDF
Bridging for lung transplantation with lumacaftor/ivacaftor
2018 · Søren Sperling Pedersen, Søren Jensen-Fangel, et al. · Breathe · 1
PDF
346 Evaluation of home monitoring for patients with cystic fibrosis a feasibility study
2017 · S.F. Sønderup, S.S. Pedersen, et al. · Journal of Cystic Fibrosis · 1
PDF
EPS6.9 Validation of lung monitor for home monitoring of patients with cystic fibrosis. A feasibility study
2017 · S.S. Pedersen, M. Jeppesen, et al. · Journal of Cystic Fibrosis · 1
Elexacaftor/tezacaftor/ivacaftor is safe and effectively reduces sino-nasal symptoms in people with cystic fibrosis post lung transplantation
2026 · Inger Hee Mazuba Mathiesen, Frederikke Falkencrone Rönsholt, et al. · Respiratory Medicine
CFTR knock-out mice exhibit impaired renal compensation to dietary NaCl depletion
2026 · Peder Berg, Amalie Quist Rousing, et al. · Journal of Cystic Fibrosis
Bone health after 3 years of ETI therapy: a real-world study from the Danish cystic fibrosis cohort
2026 · Esben Herborg Henriksen, Bibi Uhre Nielsen, et al. · Journal of Cystic Fibrosis
Management of Cystic Fibrosis‐Related Diabetes in Denmark—A Population‐Based, Cross‐Sectional Study
2026 · Ingrid Grimsgaard, Esben Herborg Henriksen, et al. · Pediatric Pulmonology
PDF
P083 Changes in health-related quality of life after the introduction of triple-modulator therapy in cystic fibrosis
2025 · M.H. Hegelund, T. Bryrup, et al. · Journal of Cystic Fibrosis
Elexacaftor/Tezacaftor/Ivacaftor (ETI) Treatment Corrects the Salt-Losing Phenotype in People with Cystic Fibrosis
2024 · Jens G. Leipziger, Samuel L.C. Svendsen, et al. · Journal of the American Society of Nephrology
P309 Evaluating changes in bone health in people with cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor therapy
2024 · E.H. Henriksen, M. Jeppesen, et al. · Journal of Cystic Fibrosis
Works count: 37
Citation count: 291
H-index: 9
I10-index: 9
Year
Topic
Type